Drug intelligence / Profile preview

hydroxymethylbutyrate + glutamine

Development stage
Unknown
Lead developer
Hospital General de México \"Dr. Eduardo Liceaga\"
Modality
Small Molecules
Administration
Oral
01

Overview

Hydroxymethylbutyrate + glutamine is a nutritional combination therapy investigated by the Hospital General de Mexico for its potential to enhance wound healing, particularly in patients with type 2 diabetes. Beta-hydroxy-beta-methylbutyrate (HMB) is a metabolite of the amino acid leucine that acts by decreasing muscle protein breakdown (proteolysis) and stimulating protein synthesis. Glutamine is a conditionally essential amino acid that serves as a fuel source for rapidly dividing cells, such as lymphocytes and enterocytes, and is crucial for collagen synthesis during wound repair. Together, this combination aims to improve tissue regeneration by decreasing apoptosis and increasing cell proliferation in bloody areas or chronic wounds.

Other names
HMB + glutaminebeta-hydroxy-beta-methylbutyrate + glutaminehydroxymethylbutyrate-Hospital General de Mexico
02

Targets

mTOR (Mammalian target of rapamycin kinase)

Beyond the preview

Go deeper on hydroxymethylbutyrate + glutamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydroxymethylbutyrate + glutamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call